Y mAbs Therapeutics (YMAB) — Defensive Interval Ratio
Y mAbs Therapeutics (YMAB) has a Defensive Interval Ratio of 250 days as of June 2025. Defensive assets of $15.74 Million (cash $-, short-term investments $-, receivables $15.74 Million) cover 250 days of daily cash needs of $62.86K/day. Check Y mAbs Therapeutics (YMAB) tangible net worth to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Y mAbs Therapeutics Defensive Interval Ratio (2016–2024)
This chart shows how Y mAbs Therapeutics's Defensive Interval Ratio has evolved across 7 annual periods from 2016 to 2024. As of June 2025, the ratio stands at 250 days, meaning defensive assets of $15.74 Million can fund 250 days of operations without new revenue. Also explore YMAB year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Y mAbs Therapeutics (2016–2024)
The table below presents the year-by-year Defensive Interval Ratio for Y mAbs Therapeutics from 2016 to 2024, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Y mAbs Therapeutics (YMAB) total market value.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 303 days | $19.69 Million | $64.93K/day | $- | $- | ▼ -104 days |
| 2023 | 407 days | $22.45 Million | $55.15K/day | $- | $- | ▲ +245 days |
| 2022 | 162 days | $12.53 Million | $77.49K/day | $- | $- | ▲ +61 days |
| 2021 | 101 days | $7.71 Million | $76.37K/day | $- | $- | ▲ +86 days |
| 2020 | 15 days | $800.00K | $53.52K/day | $- | $- | ▲ +13 days |
| 2017 | 1 days | $32.00K | $21.71K/day | $- | $32.00K | ▼ -2 days |
| 2016 | 3 days | $28.00K | $8.15K/day | $- | $28.00K | — |